We are live on
!
Find out more
WVP
Worth Venture Partners Portfolio holdings
AUM
$31.6M
1-Year Est. Return
28.5%
This Fund
S&P 500
This Quarter
Est. Return
+6.87%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$184M
AUM Growth
-$21.4M
(-10%)
Cap. Flow
-$46.6M
Cap. Flow
% of AUM
-25.37%
Top 10 Holdings %
Top 10 Hldgs %
35.95%
Holding
217
New
29
Increased
61
Reduced
33
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microchip Technology
MCHP
|
+$5.09M |
| 2 |
GSI Technology
GSIT
|
+$2.17M |
| 3 |
Annovis Bio
ANVS
|
+$1.48M |
| 4 |
Clene
CLNN
|
+$1.45M |
| 5 |
Karyopharm Therapeutics
KPTI
|
+$1.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adtran
ADTN
|
+$4.21M |
| 2 |
Silicom
SILC
|
+$2.81M |
| 3 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
+$2.59M |
| 4 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
+$2.17M |
| 5 |
Carvana
CVNA
|
+$1.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.84% |
| 2 | Healthcare | 16.62% |
| 3 | Financials | 6.45% |
| 4 | Real Estate | 2.82% |
| 5 | Consumer Staples | 1.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMBM
26
DELISTED
Cambium Networks
CMBM
| $1.12M | 0.61% |
73,841
-56,620
| -43% | -$878K |
|
27
Airgain
AIRG
$71.1M
| $974K | 0.53% |
180,358
+2,050
| +1% | +$11.5K |
|
28
Broadwind
BWEN
$81.7M
| $946K | 0.52% |
247,700
+1,700
| +0.7% | +$7.1K |
|
|
ITI
29
DELISTED
Iteris, Inc.
ITI
| $939K | 0.51% |
237,022
+24,322
| +11% | +$109K |
|
30
Cognition Therapeutics
CGTX
$80.6M
| $931K | 0.51% |
508,719
+7,000
| +1% | +$14.8K |
|
31
Fennec Pharmaceuticals
FENC
$335M
| $823K | 0.45% |
93,252
+47,814
| +105% | +$398K |
|
|
32
Karyopharm Therapeutics
KPTI
$155M
| $798K | 0.43% |
+29,732
| New | +$1.28M |
|
33
Southwest Airlines
LUV
$21.7B
| $787K | 0.43% |
21,733
-2,518
| -10% | -$79K |
|
|
BWAY
34
Brainsway
BWAY
$568M
| $721K | 0.39% |
+635,196
| New | +$569K |
|
|
THER
35
DELISTED
THERATECHNOLOGIES INC COM
THER
| $713K | 0.39% |
846,654
| – | – |
|
36
Weave Communications
WEAV
$553M
| $711K | 0.39% |
64,023
-64,678
| -50% | -$432K |
|
37
NVE Corp
NVEC
$543M
| $676K | 0.37% |
6,934
+1,576
| +29% | +$137K |
|
38
Abeona Therapeutics
ABEO
$355M
| $642K | 0.35% |
159,311
-1,200
| -0.7% | -$4.2K |
|
39
CVD Equipment Corp
CVV
$43.3M
| $617K | 0.34% |
83,739
+1,600
| +2% | +$14.3K |
|
40
Cellectar Biosciences
CLRB
$19.8M
| $611K | 0.33% |
10,450
-770
| -7% | -$37K |
|
|
SPRB
41
Spruce Biosciences
SPRB
$114M
| $597K | 0.33% |
3,702
+94
| +3% | +$15.7K |
|
42
Coya Therapeutics
COYA
$90.8M
| $596K | 0.32% |
146,493
+8,735
| +6% | +$40.5K |
|
|
ADVM
43
DELISTED
Adverum Biotechnologies
ADVM
| $589K | 0.32% |
37,068
+7,212
| +24% | +$75.8K |
|
44
Tyler Technologies
TYL
$13.7B
| $582K | 0.32% |
1,398
+494
| +55% | +$190K |
|
45
VICI Properties
VICI
$29.9B
| $569K | 0.31% |
18,098
+6,841
| +61% | +$219K |
|
|
CAMP
46
DELISTED
CalAmp Corp.
CAMP
| $544K | 0.3% |
22,327
+1,387
| +7% | +$67.4K |
|
|
MDNA
47
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
| $524K | 0.29% |
1,088,938
+35,130
| +3% | +$21.7K |
|
|
DFSC
48
DEFSEC Technologies
DFSC
$3.39M
| $480K | 0.26% |
707
+5
| +0.7% | +$3.05K |
|
49
Myomo
MYO
$35.9M
| $464K | 0.25% |
1,119,317
+873,737
| +356% | +$485K |
|
|
CTO
50
CTO Realty Growth
CTO
$839M
| $459K | 0.25% |
26,802
+500
| +2% | +$8.26K |
|
Similar funds
VL
WTG
QCA
SP
OGC
PE
RL
AIIC
Worth Venture Partners's Q2 2023 Portfolio in Review
As of Q2 2023, Worth Venture Partners held 217 positions worth $184M, down 10% from $205M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Worth Venture Partners withdrew a net $46.6M in Q2 2023, closing 50 positions and reducing 33 holdings. Its most notable exit was Adtran, an estimated $4.21M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Worth Venture Partners opened a new position in GSI Technology worth $2.76M.
- Worth Venture Partners's largest Q2 2023 buy was GSI Technology: 499,400 shares worth $2.76M.
- Worth Venture Partners added most to Microchip Technology in Q2 2023, an estimated $5.09M increase.
- Worth Venture Partners's biggest Q2 2023 reduction was Marinus Pharmaceuticals, Inc, cutting an estimated $2.59M.
- Worth Venture Partners fully exited Adtran in Q2 2023, selling an estimated $4.21M.
- Worth Venture Partners's ten largest holdings make up 36% of its $184M portfolio in Q2 2023.
- Worth Venture Partners opened 29 new positions and closed 50 in Q2 2023.
- Worth Venture Partners's portfolio value fell 10% quarter-over-quarter to $184M.
Based on Worth Venture Partners's 13F filing for Q2 2023, filed 14 Aug 2023.